The United States Food and Drug Administration (USFDA) has inspected Neuland Laboratories’ Unit 3 manufacturing facility, located at Gaddapotharam village, Jinnaram, Sangareddy District, Telangana from August 10, 2026 to August 14, 2026.
At the conclusion of the inspection, the USFDA issued a Form 483 with one observation. The observation pertains to procedural improvements in water and environmental monitoring to include new organisms beyond those listed in the United States Pharmacopeia (USP).
Neuland Laboratories is a leading manufacturer of active pharmaceutical ingredients (APIs) and an end-to-end solution provider for the pharmaceutical industry’s chemistry needs.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1900.90 |
| Dr. Reddys Labs. | 1175.00 |
| Cipla | 1426.20 |
| Lupin | 2193.00 |
| Zydus Lifesciences | 1120.00 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: